PHILIP BATH philip.bath@nottingham.ac.uk
Stroke Association Professor of Stroke Medicine
Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions
Bath, Philip M.W.; Wardlaw, Joanna M.
Authors
Joanna M. Wardlaw
Abstract
Small vessel disease encompasses lacunar stroke, white matter hyperintensities, lacunes and microbleeds. It causes a quarter of all ischemic strokes, is the commonest cause of vascular dementia, and the cause is incompletely understood. Vascular prophylaxis, as appropriate for large artery disease and cardioembolism, includes antithrombotics, and blood pressure and lipid lowering; however, these strategies may not be effective for small vessel disease, or are already used routinely so precluding further detailed study. Further, intensive antiplatelet therapy is known to be hazardous in small vessel disease through enhanced bleeding. Whether acetylcholinesterase inhibitors, which delay the progression of Alzheimer's dementia, are relevant in small vessel disease remains unclear. Potential prophylactic and treatment strategies might be those that target brain microvascular endothelium and the blood brain barrier, microvascular function and neuroinflammation. Potential interventions include endothelin antagonists, neurotrophins, nitric oxide donors and phosphodiesterase 5 inhibitors, peroxisome proliferator-activated receptor-gamma agonists, and prostacyclin mimics and phosphodiesterase 3 inhibitors. Several drugs that have relevant properties are licensed for other disorders, offering the possibility of drug repurposing. Others are in development. Since influencing multiple targets may be most effective, using multiple agents and/or those that have multiple effects may be preferable. We focus on potential small vessel disease mechanistic targets, summarize drugs that have relevant actions, and review data available from randomized trials on their actions and on the available evidence for their use in lacunar stroke.
Citation
Bath, P. M., & Wardlaw, J. M. (2015). Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. International Journal of Stroke, 10(4), https://doi.org/10.1111/ijs.12466
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 6, 2015 |
Online Publication Date | Mar 2, 2015 |
Publication Date | Jun 1, 2015 |
Deposit Date | Aug 4, 2016 |
Publicly Available Date | Aug 4, 2016 |
Journal | International Journal of Stroke |
Print ISSN | 1747-4930 |
Electronic ISSN | 1747-4949 |
Publisher | SAGE Publications |
Peer Reviewed | Peer Reviewed |
Volume | 10 |
Issue | 4 |
DOI | https://doi.org/10.1111/ijs.12466 |
Keywords | antithrombotics, blood brain barrier, blood pressure lowering, cyclic nucleotide inhibitors, nitric oxide, prostacyclin |
Public URL | https://nottingham-repository.worktribe.com/output/983262 |
Publisher URL | http://onlinelibrary.wiley.com/doi/10.1111/ijs.12466/abstract |
Files
Int J Stroke-2015-Bath-469-78.pdf
(436 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by-nc-nd/4.0
You might also like
Key design elements of successful acute ischemic stroke treatment trials
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search